X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (70518) 70518
Newspaper Article (14526) 14526
Newsletter (8771) 8771
Book Chapter (1020) 1020
Magazine Article (777) 777
Trade Publication Article (283) 283
Transcript (193) 193
Web Resource (107) 107
Book / eBook (83) 83
Dissertation (83) 83
Government Document (23) 23
Conference Proceeding (19) 19
Report (18) 18
Book Review (15) 15
Streaming Video (12) 12
Reference (8) 8
Paper (4) 4
Publication (4) 4
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (50822) 50822
science & technology (48319) 48319
life sciences & biomedicine (45342) 45342
hepatitis (35908) 35908
male (28399) 28399
female (26927) 26927
hepatitis c (23845) 23845
middle aged (21758) 21758
adult (21675) 21675
hepatitis c virus (20485) 20485
antiviral agents - therapeutic use (17006) 17006
gastroenterology & hepatology (16241) 16241
health aspects (13747) 13747
interferon (13063) 13063
hepatitis c, chronic - drug therapy (12088) 12088
drug therapy (10732) 10732
research (10624) 10624
hepatitis b (10603) 10603
infections (10440) 10440
treatment outcome (10323) 10323
aged (10061) 10061
infectious diseases (9707) 9707
liver (9608) 9608
care and treatment (8998) 8998
liver diseases (8797) 8797
medical research (8687) 8687
antiviral agents (8576) 8576
drug therapy, combination (8011) 8011
risk factors (7929) 7929
interferon-alpha - therapeutic use (7658) 7658
patients (7603) 7603
virology (7520) 7520
hepatitis c - drug therapy (7419) 7419
hepacivirus - genetics (7382) 7382
viruses (7279) 7279
genotype (6797) 6797
virus diseases (6793) 6793
analysis (6767) 6767
hepatitis b virus (6419) 6419
medicine, experimental (6167) 6167
ribavirin - therapeutic use (6093) 6093
clinical trials (5673) 5673
immunology (5508) 5508
biological response modifiers (5402) 5402
hiv (5402) 5402
human immunodeficiency virus--hiv (5397) 5397
animals (5263) 5263
pharmaceutical industry (5247) 5247
adolescent (5018) 5018
medicine (4960) 4960
liver cirrhosis (4946) 4946
pharmacology & pharmacy (4920) 4920
recombinant proteins (4901) 4901
abridged index medicus (4743) 4743
liver cancer (4715) 4715
retrospective studies (4631) 4631
antiviral agents - administration & dosage (4625) 4625
ribavirin (4524) 4524
young adult (4502) 4502
hepatology (4421) 4421
antiviral agents - adverse effects (4388) 4388
studies (4320) 4320
hepacivirus - drug effects (4278) 4278
hepatitis c - complications (4234) 4234
hepatitis b, chronic - drug therapy (4233) 4233
viral load (4205) 4205
hepatitis c, chronic - complications (4183) 4183
drugs (4131) 4131
genetic aspects (4054) 4054
hepatitis c, chronic - virology (3968) 3968
digestive system diseases (3917) 3917
research article (3912) 3912
general & internal medicine (3760) 3760
oncology (3759) 3759
medicine, general & internal (3686) 3686
hepatocellular carcinoma (3675) 3675
hiv infections - complications (3641) 3641
genotype & phenotype (3631) 3631
gastroenterology and hepatology (3560) 3560
proteins (3528) 3528
microbiology (3428) 3428
transplantation (3417) 3417
time factors (3370) 3370
polyethylene glycols - therapeutic use (3332) 3332
antiviral agents - pharmacology (3285) 3285
hepatitis b virus - genetics (3265) 3265
medicine & public health (3265) 3265
mortality (3245) 3245
infection (3218) 3218
cirrhosis (3192) 3192
hepatitis c - virology (3183) 3183
antigens (3161) 3161
gastroenterology (3140) 3140
hiv infections - drug therapy (3112) 3112
liver transplantation (3106) 3106
liver - pathology (3105) 3105
hepatitis c - epidemiology (3018) 3018
prospective studies (2945) 2945
biopsy (2912) 2912
prognosis (2911) 2911
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (24) 24
Online Resources - Online (18) 18
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (93696) 93696
French (700) 700
Spanish (640) 640
German (566) 566
Japanese (508) 508
Chinese (422) 422
Portuguese (346) 346
Russian (256) 256
Polish (172) 172
Italian (154) 154
Korean (118) 118
Hungarian (98) 98
Croatian (37) 37
Czech (33) 33
Dutch (33) 33
Turkish (33) 33
Norwegian (26) 26
Romanian (26) 26
Danish (23) 23
Serbian (20) 20
Arabic (16) 16
Swedish (16) 16
Ukrainian (11) 11
Hebrew (9) 9
Slovak (9) 9
Finnish (7) 7
Urdu (7) 7
Persian (5) 5
Bulgarian (3) 3
Bosnian (2) 2
Icelandic (2) 2
Albanian (1) 1
Hindi (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of internal medicine, ISSN 0003-4819, 11/2016, Volume 165, Issue 9, pp. 625 - 634
Journal Article
Annals of internal medicine, ISSN 0003-4819, 07/2015, Volume 163, Issue 1, pp. 1 - 13
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 06/2017, Volume 152, Issue 8, pp. 2052 - 2062.e2
Background & Aims Interferon-free direct-acting antiviral (DAA) therapies are effective in patients with hepatitis C virus... 
Gastroenterology and Hepatology | Immune Regulation | PDCD1 | Response To Treatment | Liver Disease | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | T-Lymphocyte Subsets - immunology | Prospective Studies | Hepatitis C - drug therapy | Humans | Middle Aged | Cryoglobulinemia - diagnosis | Male | Vasculitis - virology | Cryoglobulinemia - virology | Hepatitis Viruses - drug effects | Simeprevir - therapeutic use | Case-Control Studies | Simeprevir - adverse effects | Viral Load | Vasculitis - immunology | Hepatitis C - immunology | Immunity, Cellular - drug effects | Time Factors | T-Lymphocyte Subsets - drug effects | B-Lymphocyte Subsets - immunology | Female | Hepatitis C - complications | Imidazoles - therapeutic use | Sofosbuvir - adverse effects | Drug Therapy, Combination | B-Lymphocyte Subsets - virology | Cytokines - blood | Immune Tolerance - drug effects | Sofosbuvir - therapeutic use | B-Lymphocyte Subsets - drug effects | Antiviral Agents - therapeutic use | Hepatitis Viruses - immunology | Cryoglobulinemia - drug therapy | Imidazoles - adverse effects | Ribavirin - therapeutic use | Treatment Outcome | Biomarkers - blood | T-Lymphocyte Subsets - virology | Cryoglobulinemia - immunology | Hepatitis C - diagnosis | Phenotype | B-Lymphocyte Subsets - metabolism | Vasculitis - diagnosis | Ribavirin - adverse effects | T-Lymphocyte Subsets - metabolism | Antiviral Agents - adverse effects | Vasculitis - drug therapy | Aged | Care and treatment | Vasculitis | Analysis | Gastrointestinal diseases | Interferon | Biological response modifiers | Hepatitis C virus | Antiviral agents | Medical research | Liver | Medicine, Experimental | Index Medicus | Abridged Index Medicus | Life Sciences | Immunology
Journal Article
Journal of hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 4, pp. 792 - 800
Summary Hepatitis C virus (HCV) infected patients often take multiple co-medications to treat adverse events related to HCV therapy, or to manage other co-morbidities. Drug... 
Gastroenterology and Hepatology | Boceprevir | Hepatitis C virus infection | Telaprevir | Pharmacokinetics | Drug interactions | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hepatitis C, Chronic - metabolism | Antiviral Agents - pharmacokinetics | Hypnotics and Sedatives - adverse effects | Humans | Hypnotics and Sedatives - administration & dosage | Drug Interactions | Hypoglycemic Agents - administration & dosage | Drug Therapy, Combination | Immunosuppressive Agents - administration & dosage | Cardiovascular Agents - administration & dosage | Anti-Infective Agents - adverse effects | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Opiate Substitution Treatment - adverse effects | Buprenorphine - administration & dosage | Anti-Infective Agents - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Antiviral Agents - adverse effects | Buprenorphine - adverse effects | Antidepressive Agents - administration & dosage | Immunosuppressive Agents - adverse effects | Methadone - administration & dosage | Methadone - adverse effects | Antidepressive Agents - adverse effects | Cardiovascular Agents - adverse effects | Hypoglycemic Agents - adverse effects | Hepatitis C virus | Index Medicus
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2013, Volume 59, Issue 3, pp. 434 - 441
Journal Article
PloS one, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, pp. e0133236 - e0133236
Serum levels of the interferon (IFN)-stimulated chemokine CXCL10 are increased during chronic HCV infection and associate with outcome of IFN-based therapy... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Recurrence | Interferons | Humans | Fluorenes - therapeutic use | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Male | Adult | Female | Hepacivirus - physiology | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Hepacivirus - drug effects | Sofosbuvir - therapeutic use | Virus Replication - drug effects | Chemokine CXCL10 - blood | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Dipeptidyl Peptidase 4 - genetics | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Convalescence | Chemokine CXCL10 - genetics | Protein Processing, Post-Translational | Hepatitis C, Chronic - genetics | Viral Load - drug effects | Infection | Care and treatment | Analysis | Interferon | Biological response modifiers | Hepatitis C virus | Health aspects | Therapy | Laboratories | Chronic infection | Critical care | Amino acids | Infections | Ribavirin | Clinical outcomes | Proteins | Genotype & phenotype | Hepatitis | Immunology | Hepatology | Post-translation | Pretreatment | Drug dosages | Genotypes | Statistical analysis | Liver diseases | Dendritic cells | Serum levels | Studies | Infectious diseases | CXCL10 protein | Biomarkers | Chemokines | Index Medicus | Virus Replication/drug effects | Viral Load/drug effects | Dipeptidyl Peptidase 4/blood | Dipeptidyl Peptidase 4/genetics | Chemokine CXCL10/blood | Hepatitis C, Chronic/blood | Life Sciences | Hepatitis C, Chronic/drug therapy | Hepatitis C, Chronic/virology | Hepatitis C, Chronic/genetics | Chemokine CXCL10/genetics | Benzimidazoles/therapeutic use | Hepacivirus/physiology | Fluorenes/therapeutic use | Antiviral Agents/therapeutic use | Sofosbuvir/therapeutic use | Hepacivirus/drug effects | Ribavirin/therapeutic use
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 1, pp. 45 - 53
Journal Article